Global Blood Therapeutics: Q2 Earnings Insights

Global Blood Therapeutics: Q2 Earnings Insights

 

Global Blood Therapeutics GBT reported its Q2 earnings results on Monday, August 8, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Global Blood Therapeutics missed estimated earnings by 6.78%, reporting an EPS of $-1.26 versus an estimate of $-1.18.

Revenue was up $24.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 7.96% drop in the share price the next day.

Here's a look at Global Blood Therapeutics's past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -1.30 -1.13 -1.11 -1.19
EPS Actual -1.26 -1.36 -1.13 -1.12
Revenue Estimate 56.14M 55.44M 53.70M 43.84M
Revenue Actual 55.16M 56.10M 52.05M 47.55M

To track all earnings releases for Global Blood Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarningsNews